ATE129159T1 - Impfstoff. - Google Patents

Impfstoff.

Info

Publication number
ATE129159T1
ATE129159T1 AT91903336T AT91903336T ATE129159T1 AT E129159 T1 ATE129159 T1 AT E129159T1 AT 91903336 T AT91903336 T AT 91903336T AT 91903336 T AT91903336 T AT 91903336T AT E129159 T1 ATE129159 T1 AT E129159T1
Authority
AT
Austria
Prior art keywords
detoxified
pertussis toxin
vaccine
reversion
toxicity
Prior art date
Application number
AT91903336T
Other languages
English (en)
Inventor
Carine Capiau
Jean Petre
Original Assignee
Smithkline Beecham Biolog
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Biolog filed Critical Smithkline Beecham Biolog
Application granted granted Critical
Publication of ATE129159T1 publication Critical patent/ATE129159T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/099—Bordetella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/385—Haptens or antigens, bound to carriers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K2039/10—Brucella; Bordetella, e.g. Bordetella pertussis; Not used, see subgroups

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Compounds Of Unknown Constitution (AREA)
AT91903336T 1990-02-12 1991-02-07 Impfstoff. ATE129159T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US47909890A 1990-02-12 1990-02-12

Publications (1)

Publication Number Publication Date
ATE129159T1 true ATE129159T1 (de) 1995-11-15

Family

ID=23902647

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91903336T ATE129159T1 (de) 1990-02-12 1991-02-07 Impfstoff.

Country Status (17)

Country Link
EP (1) EP0515415B1 (de)
JP (1) JP3035712B2 (de)
KR (1) KR100202052B1 (de)
AT (1) ATE129159T1 (de)
AU (1) AU646019B2 (de)
CA (1) CA2075711C (de)
CY (1) CY1935A (de)
DE (1) DE69113991T2 (de)
DK (1) DK0515415T3 (de)
ES (1) ES2080941T3 (de)
GR (1) GR3018440T3 (de)
HK (1) HK1004524A1 (de)
IE (1) IE70672B1 (de)
NZ (1) NZ237069A (de)
PT (1) PT96723B (de)
WO (1) WO1991012020A1 (de)
ZA (1) ZA91947B (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0835663B1 (de) 1992-05-23 2009-09-30 GlaxoSmithKline Biologicals S.A. Kombinierte Impfstoffe, die Hepatitis B oberfläche Antigen und andere Antigenen enthalten
GB9216351D0 (en) * 1992-07-31 1992-09-16 Wellcome Found Vaccine production
ATE452651T1 (de) * 1998-09-01 2010-01-15 Merrion Res Iii Ltd Orale impfstoff-zusammensetzung
AU769539B2 (en) * 1999-01-29 2004-01-29 Zoetis Services Llc Adjuvants for use in vaccines
GB0313916D0 (en) 2003-06-16 2003-07-23 Glaxosmithkline Biolog Sa Vaccine composition
ES2653261T3 (es) 2012-02-01 2018-02-06 Glaxosmithkline Biologicals S.A. Procedimiento de fermentación
CA2879939A1 (en) 2012-08-06 2014-02-13 Glaxosmithkline Biologicals S.A. Novel method
US20140037680A1 (en) 2012-08-06 2014-02-06 Glaxosmithkline Biologicals, S.A. Novel method
DK2863943T3 (en) 2013-03-08 2016-11-07 Janssen Vaccines & Prevention Bv acellular pertussis vaccines
US9849066B2 (en) 2013-04-24 2017-12-26 Corning Incorporated Delamination resistant pharmaceutical glass containers containing active pharmaceutical ingredients
KR20160040290A (ko) 2013-08-05 2016-04-12 글락소스미스클라인 바이오로지칼즈 에스.에이. 조합 면역원성 조성물

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4070454A (en) * 1973-05-04 1978-01-24 Agence Nationale De Valorisation De La Recherche (Anvar) Vaccines, the process for preparing the same and the applications thereof
JPS5750925A (en) * 1980-09-12 1982-03-25 Takeda Chem Ind Ltd Preparation of pertussis toxoid
GB8601279D0 (en) * 1986-01-20 1986-02-26 Public Health Lab Service Purification of pertussis antigens
US4888169A (en) * 1986-10-14 1989-12-19 Norden Laboratories, Inc. Bordetella Bronchiseptica vaccine
WO1990009444A1 (en) * 1989-02-10 1990-08-23 Genesit Oy A method for producing pertussis toxin subunits

Also Published As

Publication number Publication date
KR100202052B1 (ko) 1999-06-15
ZA91947B (en) 1992-01-29
DK0515415T3 (da) 1995-11-27
HK1004524A1 (en) 1998-11-27
CA2075711C (en) 2000-11-07
CY1935A (en) 1991-02-07
DE69113991D1 (de) 1995-11-23
PT96723A (pt) 1991-10-31
WO1991012020A1 (en) 1991-08-22
IE70672B1 (en) 1996-12-11
AU646019B2 (en) 1994-02-03
CA2075711A1 (en) 1991-08-13
DE69113991T2 (de) 1996-03-21
NZ237069A (en) 1993-07-27
ES2080941T3 (es) 1996-02-16
JP3035712B2 (ja) 2000-04-24
AU7211091A (en) 1991-09-03
EP0515415B1 (de) 1995-10-18
JPH05503936A (ja) 1993-06-24
EP0515415A1 (de) 1992-12-02
GR3018440T3 (en) 1996-03-31
PT96723B (pt) 1998-07-31
KR920703099A (ko) 1992-12-17
IE910424A1 (en) 1991-08-14

Similar Documents

Publication Publication Date Title
ATE127347T1 (de) Pertussistoxin-mutanten, dieselbe produzierende bordetella-stämme und ihre verwendung als vakzin gegen pertussis.
NO165478C (no) Fremgangsmaate for fremstilling av antigeniske preparater.
DE69113991D1 (de) Impfstoff.
FR2522967B1 (fr) Conjugues d'haptenes et de muramyl-peptides, doues d'activite immunogene et compositions les contenant
GR870917B (en) Novel mehthod of preparing toxoid
NO872919D0 (no) Fremstilling av pertussis-toksin ved dyrkning av bodella pertussis.
DE69131525D1 (de) Pasteurella multocida toxoid enthaltende impfstoffe
YU41369B (en) Process for preparing benzofurnace derivatives
DE68917709D1 (de) Verfahren zur Herstellung eines Pertussis-Toxin-Toxoides.
NO892997L (no) Bordetella pertussis vaksine.
DE68917972D1 (de) Pertussistoxoid-Impfstoff.
ES2036602T3 (es) Un procedimiento de preparacion de 4'-desoxi-13(s)-dihidro-4'-yododoxorubicina.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EELA Cancelled due to lapse of time